



下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemECyclosporin ACat. No.: HY-B0579CAS No.: 59865-13-3Synonyms: Cyclosporine; Ciclosporin分式: CHNO分量: 1202.61作靶點: Others作通路: Others儲存式: 4C, protect from light* In solvent : -80C, 6 months; -20C, 1 month (protect fromlight)溶解性數(shù)據(jù)體外實驗 D
2、MSO : 62.5 mg/mL (51.97 mM; Need ultrasonic)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.08 mg/mL (1.73 mM); Suspended solution; Need ultrasonic2. 請依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.08 mg/mL (1.73 mM); Clear solution1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEBIOLOGICAL ACTIV
3、ITY物活性 Cyclosporin A種免疫抑制劑,能與親環(huán)素結(jié)合,抑制 calcineurin 活性的IC50 值為 7 nM。IC50 & Target IC50: 7 nM (calcineurin)體外研究 Cyclosporin A is able to bind with the cyclophilin in T cells 1. Cyclosporin A works by forming a Cyclophilin-Cyclosporin A complex to inhibit calcineurin 2. Cyclosporin A exhibits inhibitory
4、 effect on calcineurin with anIC50 of 7 nM 3. Cyclosporin A suppresses the nuclear translocation of NF-AT 4. Cyclosporin A shows aneffect on mitochondria via preventing the MTP from opening with an IC50 of 39 nM 5.體內(nèi)研究 Cyclosporin A has immunosuppressive activity, and is active via parenteral and p.
5、o. administration in mice,rat and guinea pigs 6. Cyclosporin A can be used in organ transplantation to prevent rejection 7.PROTOCOLKinase Assay 3 Reaction mixtures with purified enzyme contains 100 nM calcineurin, 100 nM calmodulin, and 5 M 32P-labeled phosphopeptide, in 60 L (total volume) of assay
6、 buffer containing 20 mM Tris (pH 8), 100 mM NaCl,6 mM MgCl2, 0.5 mM dithiothreitol, 0.1 mg of bovine serum albumin per mL, and either 0.1 mM CaCl2 or 5mM EGTA. Reaction mixtures with cell lysates contains 20 L of undiluted lysate, 5 M 32P-labeledphosphopeptide, and 40 L of assay buffer. Reaction mi
7、xtures contains 50 M peptide 412 or 413 and/or 500nM okadaic acid, a specific inhibitor of phosphatases 1 and 2A; 500 nM okadaic acid is sufficient for inhibitionof Ca2+-independent phosphatases, whereas higher concentrations partially inhibit Ca2+-dependent activityas well. After 15 min at 30C, rea
8、ctions are terminated by the addition of 0.5 mL of 100 mM potassiumphosphate buffer (pH 7.0) containing 5% trichloroacetic acid. Free inorganic phosphate is isolated by Dowexcation-exchange chromatography and quantitated by scintillation counting as described.MCE has not independently confirmed the
9、accuracy of these methods. They are for reference only.Cell Assay 3 Immunosuppressive agents are dissolved in ethanol at concentrations 1000-fold more than the concentrationdesired for cell treatments. Cells (106) are suspended in 1 mL of complete medium in microcentrifuge tubes;1 L of ethanol or of
10、 the ethanolic solution of Cyclosporin A is added, and the cells are incubated at 37C for1 hr. Cells are washed twice with 1 mL of PBS on ice and lysed in 50 L of hypotonic buffer containing 50mM Tris (pH 7.5); 0.1 mM EGTA; 1 mM EDTA; 0.5 mM dithiothreitol; and 50 g of phenylmethylsulfonylfluoride,
11、50 g of soybean trypsin inhibitor, 5 g of leupeptin, and 5 g of aprotinin per mL. Lysates aresubjected to three cycles of freezing in liquid nitrogen followed by thawing at 30C and then are centrifugedat 4C for 10 min at 12,000g.MCE has not independently confirmed the accuracy of these methods. They
12、 are for reference only.Animal Rats are immunized on day 0 i.p. with 0 5 mL and mice i.v. with 0 2 mL of a 10% suspension of washedAdministration 6 sheep erythrocytes (SE). To elicit a secondary response, mice are boosted 8-11 weeks after the primaryimmunization with an i.v. injection of 0-2 mL of 0
13、 25% washed SE (107 cells). For prolonged treatment theanimals receive on the average 45 mg/kg cyclosporin A daily in the food during 13 weeks. These rats areimmunized 5 days before killing.MCE has not independently confirmed the accuracy of these methods. They are for reference only.2/3 Master of S
14、mall Molecules 您邊的抑制劑師www.MedChemE戶使本產(chǎn)品發(fā)表的科研獻 Environ Sci Technol. 2017 Dec 5;51(23):13938-13948. Cell Death Dis. 2018 May 22;9(6):598. Neurobiol Dis. 2019 Sep;129:44-55. Am J Respir Cell Mol Biol. 2019 Mar 8. Toxins (Basel). 2019 Jun 18;11(6). pii: E349.See more customer validations on HYPERLINK /
15、www.MedChemEREFERENCES1. Handschumacher RE, et al. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 1984 Nov 2;226(4674):544-7.2. Liu J, et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991 Aug 23;66(4):807-15.3. Fruman
16、DA, et al. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A.1992 May 1;89(9):3686-90.4. Flanagan WM, et al. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 1991 Aug29;352(6338):803-7
17、.5. Nicolli A, et al. Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, andcyclosporin A-sensitive channel. J Biol Chem. 1996 Jan 26;271(4):2185-92.6. Borel JF, et al. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017-25.7. Williams, R, et al. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. EuropeanFK50
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- GB/T 45286-2025信息技術(shù)手持式移動設(shè)備增強現(xiàn)實系統(tǒng)技術(shù)規(guī)范
- 2025年萊蕪下載貨運從業(yè)資格證模擬考試系統(tǒng)試題
- 單位空調(diào)安裝合同范本
- 刑法中勞務(wù)合同范本
- 刊物設(shè)計制作合同范本
- 寫好運輸合同范本
- 農(nóng)戶貸款合伙經(jīng)營合同范本
- 企業(yè)重組收購合同范本
- 供熱設(shè)備買賣合同范本
- 代理銀行開戶合同范本
- 銷售人員人才畫像
- 通力電梯KCE電氣系統(tǒng)學(xué)習(xí)指南
- 整理我的小書桌(課件)小學(xué)勞動二年級通用版
- 教學(xué)課件-《旅行社業(yè)務(wù)》-(中職)
- 第二章 第一節(jié) CT設(shè)備基本運行條件
- 森林撫育施工組織設(shè)計
- 某道路拓寬工程施工組織設(shè)計
- 第一章染整工廠設(shè)計
- 上虞市化工、印染企業(yè)名單-企業(yè)負(fù)責(zé)人信息及聯(lián)系方式
- DL-T 736-2021 農(nóng)村電網(wǎng)剩余電流動作保護器安裝運行規(guī)程
- YS/T 431-2009鋁及鋁合金彩色涂層板、帶材
評論
0/150
提交評論